sever
acut
respiratori
syndrom
sar
novel
infecti
diseas
disastr
clinic
consequ
lung
major
target
organ
previou
studi
describ
gener
patholog
lung
sar
patient
identifi
cell
type
infect
sar
coronaviru
sarscov
howev
time
write
comprehens
report
cellular
distribut
viru
lung
tissu
studi
perform
doubl
label
combin
situ
hybrid
immunohistochemistri
altern
techniqu
separ
consecut
section
evalu
viral
distribut
variou
cell
type
lung
seven
patient
affect
sar
found
sarscov
present
bronchial
epithelium
type
ii
pneumocyt
lymphocyt
macrophagesmonocyt
outbreak
seemingli
new
infecti
diseas
sever
acut
respiratori
syndrom
sar
mortal
caus
death
individu
world
health
organ
http
wwwwhointcsrsarscountri
major
sar
patient
show
sever
lower
respiratori
symptom
chiefli
dri
cough
progress
dyspnea
respiratori
failur
major
caus
death
previou
report
demonstr
signific
patholog
chang
lung
tissu
sar
patient
diffus
alveolar
damag
pulmonari
edema
interstiti
mononuclear
inflammatori
infiltr
desquam
pneumocyt
alveolar
space
sar
coronaviru
sarscov
detect
pneumocyt
macrophag
lymphocyt
clinic
histopatholog
data
reveal
lung
main
target
organ
sarscov
detail
understand
patholog
pulmonari
tissu
like
provid
insight
pathogenesi
sar
role
sarscov
particular
point
howev
comprehens
descript
cell
target
sarscov
lung
tissu
case
discrep
occur
report
pulmonari
patholog
diseas
present
studi
addit
convent
histopatholog
appli
combin
situ
hybrid
immunohistochemistri
ihc
histochemistri
hc
pulmonari
tissu
evalu
cellular
distribut
viru
pneumocyt
lymphocyt
macrophag
endotheli
cell
fibroblast
lung
seven
sar
case
identifi
among
autopsi
specimen
depart
patholog
peke
univers
health
scienc
center
case
met
diagnost
criteria
sar
defin
world
health
organ
clinic
inform
patient
present
tabl
specimen
fix
formalin
embed
paraffin
lung
tissu
section
thick
consecut
section
prepar
hematoxylin
eosin
h
e
stain
perform
tissu
section
lung
tissu
three
noninfecti
pa
sever
acut
respiratori
syndrom
sar
novel
infecti
diseas
disastr
clinic
consequ
lung
major
target
organ
previou
studi
describ
gener
patholog
lung
sar
patient
identifi
cell
type
infect
sar
coronaviru
sarscov
howev
time
write
comprehens
report
cellular
distribut
viru
lung
tissu
studi
perform
doubl
label
combin
situ
hybrid
immunohistochemistri
altern
techniqu
separ
consecut
section
evalu
viral
distribut
variou
cell
type
lung
seven
patient
affect
sar
found
sarscov
present
bronchial
epithelium
type
ii
pneumocyt
lymphocyt
macrophagesmonocyt
pneumocyt
lymphocyt
macrophag
infect
rate
calcul
addit
present
studi
first
demonstr
infect
endotheli
cell
fibroblast
sar
outbreak
seemingli
new
infecti
diseas
sever
acut
respiratori
syndrom
sar
mortal
caus
death
individu
world
health
organ
http
wwwwhointcsrsarscountri
major
sar
patient
show
sever
lower
respiratori
symptom
chiefli
dri
cough
progress
dyspnea
respiratori
failur
major
caus
death
previou
report
demonstr
signific
patholog
chang
lung
tissu
sar
patient
diffus
alveolar
damag
pulmonari
edema
interstiti
mononuclear
inflammatori
infiltr
desquam
pneumocyt
alveolar
space
sar
coronaviru
sarscov
detect
pneumocyt
macrophag
lymphocyt
clinic
histopatholog
data
reveal
lung
main
target
organ
sarscov
detail
understand
patholog
pulmonari
tissu
like
provid
insight
pathogenesi
sar
role
sarscov
particular
point
howev
comprehens
descript
cell
target
sarscov
lung
tissu
case
discrep
occur
report
pulmonari
patholog
diseas
present
studi
addit
convent
histopatholog
appli
combin
situ
hybrid
immunohistochemistri
ihc
histochemistri
hc
pulmonari
tissu
evalu
cellular
distribut
viru
pneumocyt
lymphocyt
macrophag
endotheli
cell
fibroblast
lung
seven
sar
case
identifi
among
autopsi
specimen
depart
patholog
peke
univers
health
scienc
center
case
met
diagnost
criteria
sar
defin
world
health
organ
clinic
inform
patient
present
tabl
specimen
fix
formalin
embed
paraffin
lung
tissu
section
thick
consecut
section
prepar
hematoxylin
eosin
h
e
stain
perform
tissu
section
lung
tissu
three
noninfecti
patient
four
sarsneg
patient
pulmonari
infecti
diseas
serv
neg
control
total
rna
sarscov
extract
serum
sar
patient
viru
genom
sequenc
obtain
genbank
access
number
pair
primer
design
amplifi
specif
fragment
polymeras
gene
revers
transcriptasepolymeras
chain
reaction
rtpcr
nucleotid
nucleotid
amplifi
fragment
recombin
plasmid
vector
pgemt
promega
corp
madison
wi
contain
one
sali
one
ncoi
fragment
site
crna
probe
gener
vitro
transcript
label
digoxigenin
roch
diagnost
penzberg
germani
evalu
cellular
distribut
sarscov
lung
situ
hybrid
perform
base
protocol
zhang
colleagu
brief
hybrid
incub
solut
prepar
diethyl
pyrocarbonatetr
water
deparaffin
rehydr
tissu
section
treat
proteinas
k
digest
microwav
heat
incub
hybrid
cocktail
contain
gml
sar
probe
hour
block
normal
hors
serum
section
next
incub
alkalin
phosphataselabel
antidigoxigenin
antibodi
roch
diagnost
hour
reaction
product
color
nitro
blue
phosphat
nbtbcip
promega
corp
result
purpleblu
signal
slide
counterstain
methyl
green
signal
specif
assess
substitut
probe
irrelev
probe
similar
nucleotid
content
length
nucleoprotein
viru
immunohistochemistri
ihc
perform
describ
lin
colleagu
briefli
paraffinembed
tissu
section
deparaffin
immers
hydrogen
peroxid
elimin
endogen
peroxidas
activ
antigen
retriev
perform
heat
tissu
section
moll
citrat
buffer
ph
minut
primari
monoclon
antibodi
includ
cytokeratin
ck
use
identifi
epitheli
cell
lymphocyt
macrophag
endotheli
cell
respect
vimentin
immunostain
use
identifi
fibroblast
sourc
dilut
incub
time
primari
antibodi
list
tabl
optim
contrast
specif
label
background
antigen
achiev
use
immunohistochemistri
kit
contain
polyperoxidas
antimouserabbit
igg
zyme
laboratori
south
san
francisco
ca
visual
specif
signal
dab
doubl
label
combin
situ
hybrid
ihc
use
identifi
cell
type
situ
hybridizationposit
cell
situ
hybrid
color
reaction
section
incub
hydrogen
peroxid
quench
endogen
peroxidas
activ
react
monoclon
antibodi
cytokeratin
ck
vimentin
incub
overnight
wash
phosphatebuff
salin
section
incub
goat
antimous
igg
label
horseradish
peroxidas
room
temperatur
minut
antibodi
bind
cell
interest
detect
horseradish
peroxidas
reaction
kit
aec
give
red
reaction
color
everi
case
doubl
label
ihc
situ
hybrid
repeat
three
time
data
analysi
strengthen
result
coloc
perform
situ
hybrid
ihc
consecut
section
tissu
section
show
situ
hybridizationposit
cell
care
compar
consecut
tissu
section
ihc
antibodi
specif
cell
marker
appli
coloc
specif
cellular
marker
viral
genom
clearli
identifi
addit
vimentin
immunostain
masson
trichrom
stain
use
consecut
tissu
section
mean
identifi
fibroblast
sourc
compon
masson
trichrom
stain
list
tabl
paraffinembed
tissu
section
deparaffin
treat
sequenti
solut
trichloroacet
acid
potassium
dichrom
celestin
blue
mayer
hematoxylin
fuchsin
acid
ponceau
next
section
rins
phosphomolybd
acid
tetracosahydr
acet
acid
final
light
green
ad
section
rins
phosphomolybd
acid
tetracosahydr
acet
acid
five
field
per
section
ihcposit
cell
rel
abund
select
randomli
use
light
microscop
object
nikon
eclips
yokohama
japan
select
field
show
mainli
bronchi
bronchiol
alveoli
cell
posit
one
specif
ihc
marker
count
cell
show
posit
situ
hybrid
ihc
signal
posit
doubl
label
also
count
ident
cell
show
coloc
confirm
perform
situ
hybrid
ihc
separ
consecut
section
describ
infect
rate
three
cell
type
identifi
ihc
deriv
cell
count
cell
show
posit
doubl
labelingtot
number
cell
posit
specif
ihc
marker
evalu
perform
doubleblind
manner
infect
rate
three
cell
type
grade
accord
follow
criteria
cell
infect
rate
less
regard
grade
mark
cell
infect
rate
regard
grade
ii
mark
cell
infect
rate
exceed
regard
grade
iii
mark
infect
rate
specif
cell
type
semiquantif
infect
rate
present
tabl
infect
rate
endotheli
cell
fibroblast
calcul
absolut
number
infect
endotheli
cell
small
lack
specif
marker
fibroblast
gener
bronchial
epithelium
found
intact
light
microscop
evalu
epithelium
focal
detach
case
intact
detach
epithelium
show
strong
posit
situ
hybrid
signal
doubl
label
combin
situ
hybrid
ihc
antibodi
ck
confirm
ident
cell
epitheli
cell
figur
e
mani
roundand
spindleshap
cell
scatter
cluster
collaps
alveolar
space
morpholog
featur
cell
consist
type
ii
pneumocyt
figur
posit
ihc
antibodi
ck
confirm
epitheli
cell
figur
situ
hybrid
consecut
section
doubl
label
show
epitheli
cell
harbor
sarscov
genom
sequenc
figur
c
f
posit
situ
hybrid
posit
ihc
signal
also
found
local
cytoplasm
alveolar
line
cell
morpholog
characterist
type
pneumocyt
figur
infect
rate
ckposit
cell
shown
tabl
averag
infect
rate
seven
case
highest
infect
rate
found
case
respect
repres
youngest
two
patient
seri
sar
case
tabl
lung
tissu
present
sar
case
signific
number
inflammatori
cell
found
alveolar
space
interstitium
strong
posit
situ
hybrid
signal
present
mani
round
ckneg
cell
like
repres
inflammatori
cell
figur
ihc
show
sever
cell
figur
addit
mani
cell
larg
foami
vacuol
featur
consist
gener
morpholog
macrophag
figur
doubl
label
combin
situ
hybrid
ihc
antibodi
show
subset
larg
cell
viral
genom
sequenc
present
figur
addit
also
small
cell
sarscov
detect
figur
mani
cell
express
also
found
scatter
interstitium
figur
consecut
section
situ
hybrid
demonstr
sarscov
could
detect
cytoplasm
sever
cell
figur
b
c
doubl
label
confirm
infect
lymphocyt
figur
infect
rate
cell
shown
tabl
averag
infect
rate
cell
seven
case
wherea
higher
percentag
infect
cell
observ
case
posit
situ
hybrid
signal
clearli
present
cytoplasm
endotheli
cell
figur
lung
case
show
zone
mark
fibrosi
figur
within
zone
spindleshap
cell
strongli
posit
signal
detect
situ
hybrid
doubl
label
combin
situ
hybrid
ihc
demonstr
cell
vimentinposit
figur
ckneg
figur
find
cell
locat
within
area
fibrosi
well
spindleshap
histomorpholog
absenc
ck
reactiv
vimentinposit
stain
support
presumpt
cell
fibroblast
masson
trichrom
stain
consecut
section
also
demonstr
stain
cell
appropri
fibroblast
figur
specif
situ
hybrid
ihc
doubl
label
establish
neg
result
neg
control
figur
scatter
plot
compar
infect
rate
cell
ck
cell
appear
show
neg
correl
exclud
case
figur
spearman
correl
coeffici
p
valu
includ
seven
case
respect
spearman
correl
test
exclud
case
show
neg
correl
spearman
correl
coeffici
although
lack
statist
signific
p
scatter
plot
compar
variabl
show
obviou
linear
trend
scatter
plot
shown
although
last
sar
outbreak
year
past
pathogenesi
diseas
still
incomplet
understood
particular
detail
patholog
cell
type
infect
distribut
quantiti
major
target
organ
sar
thoroughli
investig
present
studi
situ
hybrid
ihc
hc
use
profil
cellular
distribut
sarscov
pulmonari
tissu
consist
previou
studi
sarscov
found
readili
identifi
pneumocyt
bronchial
epithelium
macrophag
lymphocyt
noteworthi
case
rel
short
clinic
cours
patholog
chang
lung
still
rel
earli
phase
high
percentag
pneumocyt
lymphocyt
infect
patholog
signific
infect
immun
cell
recent
discuss
gu
colleagu
argu
infect
immun
cell
lymphocyt
macrophagesmonocyt
may
carri
sarscov
variou
organ
manifest
widespread
dissemin
furthermor
direct
infect
subsequ
damag
immun
cell
may
result
transient
compromis
immun
system
could
aggrav
pulmonari
injuri
sarscov
infect
macrophag
may
play
addit
role
pathogenesi
sar
lung
vitro
experi
demonstr
infect
macrophag
induc
express
certain
chemokin
addit
littl
interferon
respons
could
elicit
sarscov
infect
macrophag
experi
increas
level
chemokin
defici
respons
may
result
exacerb
local
inflammatori
reaction
sar
lung
found
sarscov
larg
small
cell
latter
cell
like
repres
small
nonactiv
macrophagesmonocyt
would
suggest
viru
ingest
activ
macrophag
may
also
capabl
directli
infect
small
nonactiv
macrophag
monocyt
previou
report
sar
extens
patholog
lesion
hemorrhag
edema
vascul
thrombu
describ
appear
directli
relat
vascular
endotheli
injuri
patholog
chang
may
contribut
among
factor
caus
reduc
oxygen
found
sar
patient
studi
found
sarscov
capabl
infect
vascular
endotheli
cell
may
indic
direct
infect
cell
partli
account
observ
injuri
vascular
endothelium
howev
pauciti
infect
endotheli
cell
seem
insuffici
explain
sever
vascular
injuri
previou
studi
report
high
level
variou
cytokin
chemokin
serum
sar
patient
therefor
assum
addit
direct
viral
infect
hyperinduct
proinflammatori
mediat
hypoxia
may
play
import
role
injuri
vascular
endothelium
sar
patient
patholog
two
type
pulmonari
fibrosi
interstiti
intraalveolar
observ
sar
fibroblast
activ
overexpress
collagen
import
aspect
pathogenesi
fibrosi
injur
epitheli
cell
infiltr
inflammatori
cell
elev
cytokin
import
role
process
activ
fibroblast
collagen
synthesi
find
direct
sarscov
infect
fibroblast
suggest
sarscov
protein
may
interact
host
cell
thu
contribut
activ
fibroblast
excess
product
collagen
distribut
viru
cell
lung
sar
patient
unveil
studi
rais
question
mechan
infect
divers
cell
type
angiotensinconvert
enzym
identifi
function
receptor
sarscov
receptor
express
abundantli
tracheal
epithelium
pneumocyt
vascular
endothelium
lymphocyt
macrophag
fibroblast
thu
possibl
sarscov
infect
epitheli
cell
trachea
pneumocyt
vascular
endotheli
cell
express
interact
spike
protein
replic
cell
caus
intercellular
transmiss
howev
mechan
sarscov
infect
cell
express
receptor
unclear
studi
lymphocyt
macrophag
harbor
viral
genom
sequenc
high
infect
rate
despit
absenc
express
possibl
explan
cell
macrophag
infect
contact
basolater
aspect
infect
epitheli
cell
direct
cellcel
contact
engulf
measl
kind
indirect
infect
describ
account
infect
tissueresid
macrophag
dendrit
cell
addit
receptor
may
play
role
direct
infect
cell
lymph
nodespecif
nonintegrin
lsign
dendriticcellspecif
nonintegrin
dcsign
report
function
receptor
sarscov
dcsign
express
detect
certain
type
dendrit
cell
alveolar
macrophag
may
explain
presenc
sarscov
genom
sequenc
lung
tissu
macrophag
observ
studi
howev
vitro
experi
demonstr
cell
express
dcsign
lsign
without
partial
suscept
sarscov
infect
suggest
receptor
much
less
effici
receptor
mere
enhanc
infect
suscept
cell
find
suggest
receptor
andor
cofactor
may
involv
interact
viru
target
cell
report
express
effici
endotheli
cell
nevertheless
case
endotheli
cell
show
posit
viral
express
studi
new
human
cell
cultur
model
indic
presenc
alon
insuffici
maintain
viral
infect
huang
colleagu
suggest
cathepsin
l
may
facilit
sarscov
infect
mediat
spike
protein
matur
endotheli
cell
express
rel
low
level
cathepsin
l
